Literature DB >> 27286699

MicroRNA-1 properties in cancer regulatory networks and tumor biology.

Martin Weiss1, Lars-Ove Brandenburg2, Martin Burchardt1, Matthias B Stope3.   

Abstract

Short non-coding microRNAs have been identified to orchestrate crucial mechanisms in cancer progression and treatment resistance. MicroRNAs are involved in posttranscriptional modulation of gene expression and therefore represent promising targets for anticancer therapy. As mircoRNA-1 (miR-1) exerted to be predominantly downregulated in the majority of examined tumors, miR-1 is classified to be a tumor suppressor with high potential to diminish tumor development and therapy resistance. Here we review the complex functionality of miR-1 in tumor biology.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Biomarker; Cancer; Cellular response; Resistance; microRNA-1

Mesh:

Substances:

Year:  2016        PMID: 27286699     DOI: 10.1016/j.critrevonc.2016.05.014

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  8 in total

1.  MicroRNA-1 and MicroRNA-21 Individually Regulate Cellular Growth of Non-malignant and Malignant Renal Cells.

Authors:  Hannes Ahrend; Anne Kaul; Susanne Ziegler; Lars-Ove Brandenburg; Uwe Zimmermann; Alexander Mustea; Martin Burchardt; Patrick Ziegler; Matthias B Stope
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

2.  Physiological and Genetically Engineered Expression Modulation Methods Do Not Affect Cellular Levels of the Heat Shock Protein HSP60 in Prostate Cancer Cells.

Authors:  Holger H H Erb; Andreas Streitbörger; Alexander Mustea; Matthias B Stope
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

3.  miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells.

Authors:  Junjie Niu; Yibao Sun; Qiaoge Guo; Dongju Niu; Bo Liu
Journal:  Dis Markers       Date:  2016-09-29       Impact factor: 3.434

Review 4.  miR-133b, a particular member of myomiRs, coming into playing its unique pathological role in human cancer.

Authors:  Daojiang Li; Lu Xia; Miao Chen; Changwei Lin; Hao Wu; Yi Zhang; Songqing Pan; Xiaorong Li
Journal:  Oncotarget       Date:  2017-07-25

5.  MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS.

Authors:  Junkai Chang; Weibo Xu; Xinyi Du; Junqing Hou
Journal:  Onco Targets Ther       Date:  2018-06-15       Impact factor: 4.147

6.  Analysis of association between MALAT1 haplotype and the severity of normal-tension glaucoma (NTG).

Authors:  Jin-Liang Yue; Shu-Feng Zheng
Journal:  J Cell Mol Med       Date:  2021-10-02       Impact factor: 5.310

7.  The Clinical Significance of Changes in the Expression Levels of MicroRNA-1 and Inflammatory Factors in the Peripheral Blood of Children with Acute-Stage Asthma.

Authors:  Man Tian; Ying Zhou; Haoyuan Jia; Xuming Zhu; Yubao Cui
Journal:  Biomed Res Int       Date:  2018-06-26       Impact factor: 3.411

8.  Programmed Death Ligand-1 (PD-L1) Regulated by NRF-2/MicroRNA-1 Regulatory Axis Enhances Drug Resistance and Promotes Tumorigenic Properties in Sorafenib-Resistant Hepatoma Cells.

Authors:  Dong Li; Fei-Fan Sun; Dan Wang; Tao Wang; Jing-Jing Peng; Jian-Qiong Feng; Hua Li; Chao Wang; Dai-Jun Zhou; Hong Luo; Zeng-Qiang Fu; Tao Zhang
Journal:  Oncol Res       Date:  2020-06-19       Impact factor: 5.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.